Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0783 USD | -5.65% | -2.12% | -90.79% |
May. 13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P Global BMI Index | CI |
May. 13 | Vaxxinity, Inc.(OTCPK:VAXX) dropped from S&P TMI Index | CI |
Chart calendar Vaxxinity, Inc.
Upcoming events on Vaxxinity, Inc.
Past events on Vaxxinity, Inc.
2024-05-06 | Q1 2024 Earnings Release (Projected) |
2024-04-16 07:54 pm | American Academy of Neurology Meeting |
2024-03-27 04:41 pm | Q4 2023 Earnings Release |
2024-03-06 01:00 pm | Alzheimer and Parkinson Diseases International Conference |
2024-03-04 | Alzheimer and Parkinson Diseases International Conference - Poster No:P1049 |
2024-03-04 | Alzheimer and Parkinson Diseases International Conference - Poster No:P0770 |
2024-01-11 01:30 pm | JPMorgan Healthcare Conference |
2023-11-29 10:25 am | Evercore ISI HealthCONx Conference - Fireside Chat |
2023-11-15 11:30 am | Jefferies London Healthcare Conference - Fireside Chat |
2023-11-14 12:20 pm | Vaccines Summit |
2023-11-08 08:30 am | Q3 2023 Earnings Release |
2023-09-12 11:25 am | Baird Global Healthcare Conference |
2023-09-11 05:00 pm | H.C. Wainwright Global Investment Conference |
2023-08-09 08:00 am | Q2 2023 Earnings Release |
2023-06-20 10:00 am | Annual General Meeting |
2023-05-09 08:00 am | Q1 2023 Earnings Release |
2023-04-24 11:15 am | AAN Meeting - Jean-Cosme Dodart |
2023-04-23 05:20 am | British Neuroscience Association Festival of Neuroscience Conference - Jean-Cosme Dodart |
2023-04-06 12:00 pm | World Vaccine Congress - Alexander Rumyantsev |
2023-04-06 10:10 am | World Vaccine Congress - Mei Mei Hu |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,07 0,05 32% | 0,00 0,00 - |
EBITDA Million USD | Released Forecast Spread | 0,00 | -124 -108 -14.71% | -74,2 -75,1 1.16% |
EBIT Million USD | Released Forecast Spread | 0,00 | -125 -106 -18.28% | -76,0 -75,6 -0.48% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -137 -107 -28.68% | -75,2 -75,3 0.1% |
Net income Million USD | Released Forecast Spread | -40,0 | -137 -103 -33.71% | -75,2 -75,5 0.36% |
EPS USD | Released Forecast Spread | -0,39 | -1,79 -1,39 -28.78% | -0,60 -0,60 -0.84% |
Announcement Date | 06/08/21 | 24/03/22 | 27/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
EBITDA Million USD | Released Forecast Spread | -47,4 -36,0 -31.72% | -13,9 -17,9 22.22% | ||||||
EBIT Million USD | Released Forecast Spread | -47,9 -30,4 -57.41% | -18,2 -32,1 43.45% | -17,2 -30,9 44.3% | -19,8 -19,5 -1.47% | -20,8 -20,5 -1.63% | -18,8 -20,5 8.27% | -14,4 -20,1 28.4% | -13,4 -14,9 9.96% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,2 -24,0 -100.8% | -18,3 -30,7 40.51% | -17,3 -18,5 6.75% | -19,3 -17,6 -9.39% | -20,5 -20,2 -1.27% | -18,4 -21,9 15.89% | -14,0 -19,4 27.95% | -13,1 -14,8 11.42% |
Net income Million USD | Released Forecast Spread | -48,2 -30,6 -57.54% | -18,3 -33,7 45.78% | -17,3 -31,0 44.31% | -19,3 -19,5 1.27% | -20,5 -20,6 0.51% | -18,4 -20,7 11.03% | -14,0 -20,2 30.85% | -13,1 -14,8 11.42% |
EPS USD | Released Forecast Spread | -0,49 -0,38 -30.67% | -0,15 -0,34 55.88% | -0,14 -0,38 62.67% | -0,15 -0,16 3.23% | -0,17 -0,16 -6.25% | -0,15 -0,16 6.25% | -0,11 -0,16 29.03% | -0,10 -0,12 16.67% |
Announcement Date | 24/03/22 | 09/05/22 | 11/08/22 | 10/11/22 | 27/03/23 | 09/05/23 | 09/08/23 | 08/11/23 |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Vaxxinity, Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VAXX Stock
- Calendar Vaxxinity, Inc.